Cargando...
Small molecule drug development for rare genodermatoses – evaluation of the current status in epidermolysis bullosa
BACKGROUND: Hereditary epidermolysis bullosa (EB) comprises a heterogeneous group of rare genodermatoses, which are caused by mutations in genes involved in the maintenance of the structural and functional integrity of dermo-epidermal adhesion in various stratified epithelia. In severe variants, gen...
Guardado en:
| Publicado en: | Orphanet J Rare Dis |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7574495/ https://ncbi.nlm.nih.gov/pubmed/33076941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01467-9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|